Literature DB >> 11828368

IFN-gamma-producing CD45RA+CD8+ and IL-10-producing CD45RA-CD4+ T cells generated in response to LACK in naive subjects never exposed to Leishmania.

Eliane Bourreau1, Marion Collet, Ghislaine Prévot, Geneviève Milon, Dominique Ashimoff, Hitoshi Hasagewa, Carlos Parra-Lopez, Pascal Launois.   

Abstract

Leishmania guyanensis (L.g.)-specific CD8+ T cells can be isolated from PBMC of subjects who have never been previously exposed to Leishmania. Cells that produce IFN-gamma in response to live L.g. are generated from naive CD45RA+CD8+ T cells. The generation of L.g.-specific CD8+ T cells requires the presence of whole L.g. or UV-irradiated parasite but not the soluble antigens from L.g. promastigotes. The IFN-gamma-producing T cells recognize a specific antigen, the Leishmania homologue of receptors of activated C kinases (LACK) and this antigen but not live L.g. can produce a strong IL-10 response in CD45RA-CD4+ memory T cells from naive subjects. A single epitope (amino acid 156-173) is found to induce the IL-10 synthesis. While the IFN-gamma-producing cells are present among CD45RA+CD8+ T cells that are CD62L-CDR7- and CLA-, the LACK-reactive IL-10-producing cells are CD4+ T cells that are CD62L+CCR7- and CLA-.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828368     DOI: 10.1002/1521-4141(200202)32:2<510::AID-IMMU510>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis.

Authors:  A Kariminia; E Bourreau; H Pascalis; P Couppié; D Sainte-Marie; F Tacchini-Cottier; P Launois
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  Hervé Pascalis; Anne Lavergne; Eliane Bourreau; Ghislaine Prévot-Linguet; Amina Kariminia; Roger Pradinaud; Sima Rafati; Pascal Launois
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection.

Authors:  Eliane Bourreau; Ghislaine Prévot; Jacques Gardon; Roger Pradinaud; Hitoshi Hasagewa; Geneviève Milon; Pascal Launois
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection.

Authors:  Mark T M Roberts; Carmel B Stober; Andrew N McKenzie; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Early Cutaneous Leishmaniasis Patients Infected With Leishmania braziliensis Express Increased Inflammatory Responses After Antimony Therapy.

Authors:  Rúbia S Costa; Lucas P Carvalho; Taís M Campos; Andréa S Magalhães; Sara T Passos; Albert Schriefer; Juliana A Silva; Ednaldo Lago; Camilla S Paixão; Paulo Machado; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

6.  Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization.

Authors:  R B G Azeredo-Coutinho; D C S Matos; G G R Armôa; R M Maia; A Schubach; W Mayrink; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2008-07-08       Impact factor: 4.330

7.  Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response.

Authors:  Carolina Ramírez; Yira Díaz-Toro; Jair Tellez; Tiago M Castilho; Ricardo Rojas; Nicholas A Ettinger; Irina Tikhonova; Neal D Alexander; Liliana Valderrama; Janet Hager; Mary E Wilson; Aiping Lin; Hongyu Zhao; Nancy G Saravia; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

8.  Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Authors:  Christodoulos Filippis; Katharina Arens; Gaetan Aime Noubissi Nzeteu; Gabriele Reichmann; Zoe Waibler; Peter Crauwels; Ger van Zandbergen
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

9.  Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.

Authors:  Laura Fernández; Eugenia Carrillo; Lucas Sánchez-Sampedro; Carmen Sánchez; Ana Victoria Ibarra-Meneses; M Angeles Jimenez; Valter Dos Anjos Almeida; Mariano Esteban; Javier Moreno
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.